Ergönül O. Crimean-Congo haemorrhagic fever. Lancet Infect Dis. 2006;6:203–14. DOIPubMedGoogle Scholar
Spengler JR, Bergeron É, Spiropoulou CF. Crimean-Congo hemorrhagic fever and expansion from endemic regions. Curr Opin Virol. 2019;34:70–8. DOIPubMedGoogle Scholar
Lorenzo Juanes HM, Carbonell C, Sendra BF, López-Bernus A, Bahamonde A, Orfao A, et al. Crimean-Congo hemorrhagic fever, Spain, 2013–2021. Emerg Infect Dis. 2023;29:252–9. DOIPubMedGoogle Scholar
Zé-Zé L, Nunes C, Sousa M, de Sousa R, Gomes C, Santos AS, et al. Fatal case of Crimean-Congo hemorrhagic fever, Portugal, 2024. Emerg Infect Dis. 2025;31:139–43. DOIPubMedGoogle Scholar
Pervanidou D, Georgiadou S, Stavropoulou E, Stefos A, Tsioka K, Kefaloudi CN, et al. Two autochthonous cases of Crimean-Congo haemorrhagic fever and the One Health response, Thessaly, Greece, 2025. Euro Surveill. 2025;30:50. DOIPubMedGoogle Scholar
Karanam SK, Nagvishnu K, Uppala PK, Edhi S, Varri SR. Crimean-Congo hemorrhagic fever: pathogenesis, transmission and public health challenges. World J Virol. 2025;14:100003. DOIPubMedGoogle Scholar
World Health Organization. Crimean-Congo haemorrhagic fever. 2025 Feb 20 [cited 2025 Dec 29]. https://www.who.int/news-room/fact-sheets/detail/crimean-congo-haemorrhagic-fever
Cornish EF, Filipovic I, Åsenius F, Williams DJ, McDonnell T. Innate immune responses to acute viral infection during pregnancy. Front Immunol. 2020;11:572567. DOIPubMedGoogle Scholar
Sayres L, Hughes BL. Contemporary understanding of Ebola and Zika virus in pregnancy. Clin Perinatol. 2020;47:835–46. DOIPubMedGoogle Scholar
Pshenichnaya NY, Leblebicioglu H, Bozkurt I, Sannikova IV, Abuova GN, Zhuravlev AS, et al. Crimean-Congo hemorrhagic fever in pregnancy: a systematic review and case series from Russia, Kazakhstan and Turkey. Int J Infect Dis. 2017;58:58–64. DOIPubMedGoogle Scholar
Kahraman E, Celina SS. Crimean-Congo haemorrhagic fever in pregnancy: clinical outcomes and public health implications. Front Public Health. 2026;13:1722564. DOIPubMedGoogle Scholar
Ergonul O, Celikbas A, Yildirim U, Zenciroglu A, Erdogan D, Ziraman I, et al. Pregnancy and Crimean-Congo haemorrhagic fever. Clin Microbiol Infect. 2010;16:647–50. DOIPubMedGoogle Scholar
Stewart LA, Clarke M, Rovers M, Riley RD, Simmonds M, Stewart G, et al.; PRISMA-IPD Development Group. Preferred reporting items for systematic review and meta-analyses of individual participant data: the PRISMA-IPD statement. JAMA. 2015;313:1657–65. DOIPubMedGoogle Scholar
Soma-Pillay P, Nelson-Piercy C, Tolppanen H, Mebazaa A. Physiological changes in pregnancy. Cardiovasc J S Afr. 2016;27:89–94. DOIPubMedGoogle Scholar
Ren D, Fu S, Yan T, Ni T, Zhang Z, Zhang M, et al. The clinical characteristics and outcomes of hemorrhagic fever with renal syndrome in pregnancy. Front Med (Lausanne). 2022;9:839224. DOIPubMedGoogle Scholar
Mor G, Cardenas I, Abrahams V, Guller S. Inflammation and pregnancy: the role of the immune system at the implantation site. Ann N Y Acad Sci. 2011;1221:80–7. DOIPubMedGoogle Scholar
Auriti C, De Rose DU, Santisi A, Martini L, Piersigilli F, Bersani I, et al. Pregnancy and viral infections: mechanisms of fetal damage, diagnosis and prevention of neonatal adverse outcomes from cytomegalovirus to SARS-CoV-2 and Zika virus. Biochim Biophys Acta Mol Basis Dis. 2021;1867:166198. DOIPubMedGoogle Scholar
Schneider E, Kinzler WL. Placental abruption: pathophysiology, diagnosis, and management. Clin Obstet Gynecol. 2025;68:98–104. DOIPubMedGoogle Scholar
US Food and Drug Administration. Content and format of labeling for human prescription drug and biological products; requirements for pregnancy and lactation labeling. Report no. NDA 021511. Silver Spring (MD). Rev ADM. 2014.
Frank MG, Weaver G, Raabe V; State of the Clinical Science Working Group of the National Emerging Pathogens Training Education Center’s Special Pathogens Research Network. Crimean-Congo hemorrhagic fever virus for clinicians—epidemiology, clinical manifestations, and prevention. Emerg Infect Dis. 2024;30:854–63. DOIPubMedGoogle Scholar
Mor G, Aldo P, Alvero AB. The unique immunological and microbial aspects of pregnancy. Nat Rev Immunol. 2017;17:469–82. DOIPubMedGoogle Scholar
Sykes L, MacIntyre DA, Yap XJ, Teoh TG, Bennett PR. The Th1:Th2 dichotomy of pregnancy and preterm labour. Mediators Inflamm. 2012;2012:967629. DOIPubMedGoogle Scholar
Sappenfield E, Jamieson DJ, Kourtis AP. Pregnancy and susceptibility to infectious diseases. Infect Dis Obstet Gynecol. 2013;2013:752852. DOIPubMedGoogle Scholar
Bebell LM, Oduyebo T, Riley LE. Ebola virus disease and pregnancy: a review of the current knowledge of Ebola virus pathogenesis, maternal, and neonatal outcomes. Birth Defects Res. 2017;109:353–62. DOIPubMedGoogle Scholar
Racicot K, Mor G. Risks associated with viral infections during pregnancy. J Clin Invest. 2017;127:1591–9. DOIPubMedGoogle Scholar
Ajazaj-Berisha L, Halili B, Ndrejaj V, Sherifi K, Jakupi X, Priesnitz S, et al. Crimean-Congo hemorrhagic fever mimicking HELLP syndrome in a pregnant woman and her infant in Kosovo: a case report. Viruses. 2025;17:178. DOIPubMedGoogle Scholar
Erbay A, Çevik MA, Önguru P, Gözel G, Akinci E, Kubar A, et al. Breastfeeding in Crimean-Congo haemorrhagic fever. Scand J Infect Dis. 2008;40:186–8. DOIPubMedGoogle Scholar
Yagci-Caglayik D, Kayaaslan B, Yapar D, Kocagul-Celikbas A, Ozkaya-Parlakay A, Emek M, et al. Monitoring Crimean-Congo haemorrhagic fever virus RNA shedding in body secretions and serological status in hospitalised patients, Turkey, 2015. Euro Surveill. 2020;25:10. DOIPubMedGoogle Scholar
Dizbay M, Aktas F, Gaygisiz U, Ozger HS, Ozdemir K. Crimean-Congo hemorrhagic fever treated with ribavirin in a pregnant woman. J Infect. 2009;59:281–3. DOIPubMedGoogle Scholar
Arab-Bafrani Z, Jabbari A, Mostakhdem Hashemi M, Arabzadeh AM, Gilanipour A, Mousavi E. Identification of the crucial parameters regarding the efficacy of ribavirin therapy in Crimean-Congo haemorrhagic fever (CCHF) patients: a systematic review and meta-analysis. J Antimicrob Chemother. 2019;74:3432–9. DOIPubMedGoogle Scholar
Güllü D, Yigci D, Baykam N, Çelikbaş AK, Yapar D, Akdoğan Ö, et al. Key predictors of mortality in Crimean-Congo haemorrhagic fever: a retrospective multicentre cohort study. Clin Microbiol Infect. 2025;31:2056–62. DOIPubMedGoogle Scholar
Sinclair SM, Jones JK, Miller RK, Greene MF, Kwo PY, Maddrey WC. The Ribavirin Pregnancy Registry: an interim analysis of potential teratogenicity at the mid-point of enrollment. Drug Saf. 2017;40:1205–18. DOIPubMedGoogle Scholar
